Incidence of and risk factors for type-specific anal human papillomavirus infection among HIV-positive MSM. Read more about Incidence of and risk factors for type-specific anal human papillomavirus infection among HIV-positive MSM.
CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda. Read more about CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda.
A closer look at hepatitis C clearance in HIV controllers: a response. Read more about A closer look at hepatitis C clearance in HIV controllers: a response.
Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis. Read more about Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis.
Paclitaxel for relapsed or recurrent HIV-associated pediatric Kaposi's sarcoma. Read more about Paclitaxel for relapsed or recurrent HIV-associated pediatric Kaposi's sarcoma.
Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection. Read more about Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection.
Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma. Read more about Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma.
A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+ T cells, including myeloid cells. Read more about A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+ T cells, including myeloid cells.
Treatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda. Read more about Treatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda.
Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers. Read more about Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers.
